Literature DB >> 18320305

Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment.

Rukhsana Sultana1, Marta Piroddi, Francesco Galli, D Allan Butterfield.   

Abstract

Mild cognitive impairment (MCI) is generally referred to the transitional zone between normal cognitive aging and early dementia or clinically probable Alzheimer's disease (AD). Most individuals with amnestic MCI eventually develop AD, which suggests that MCI may be the earliest phase of AD. Oxidative stress is observed in brain from subjects with both AD and MCI. Among others, two possibilities for elevated oxidative stress are decreased activity or elevated expression of antioxidant enzymes, the latter as a response to the former. Accordingly, in the current study, the protein levels and activity of some antioxidant enzymes in the hippocampus of control and MCI brain were measured using Western blot analysis and spectrophotometric methods, respectively. Alterations in the levels and activity of a number of antioxidant enzymes in MCI brain compared to age-matched controls were found. These results are consistent with the hypothesis that oxidative stress may be an early event in the progression of amnestic MCI to AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320305     DOI: 10.1007/s11064-008-9593-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Mild cognitive impairment: transition between aging and Alzheimer's disease.

Authors:  R C Petersen
Journal:  Neurologia       Date:  2000-03       Impact factor: 3.109

2.  Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

Authors:  D Allan Butterfield; Tanea T Reed; Marzia Perluigi; Carlo De Marco; Raffaella Coccia; Jeffrey N Keller; William R Markesbery; Rukhsana Sultana
Journal:  Brain Res       Date:  2007-03-07       Impact factor: 3.252

3.  The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease.

Authors:  A M Palmer
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

Review 4.  Multiple roles of glutathione in the central nervous system.

Authors:  A J Cooper; B S Kristal
Journal:  Biol Chem       Date:  1997-08       Impact factor: 3.915

5.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Proteomic identification of nitrated proteins in Alzheimer's disease brain.

Authors:  Alessandra Castegna; Visith Thongboonkerd; Jon B Klein; Bert Lynn; William R Markesbery; D Allan Butterfield
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

8.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

Review 9.  Natural antioxidants in Alzheimer's disease.

Authors:  Cesare Mancuso; Timothy E Bates; D Allan Butterfield; Stella Calafato; Carolin Cornelius; Antonino De Lorenzo; Albena T Dinkova Kostova; Vittorio Calabrese
Journal:  Expert Opin Investig Drugs       Date:  2007-12       Impact factor: 6.206

Review 10.  Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system.

Authors:  G Benzi; A Moretti
Journal:  Free Radic Biol Med       Date:  1995-07       Impact factor: 7.376

View more
  31 in total

Review 1.  Elevation of glutathione as a therapeutic strategy in Alzheimer disease.

Authors:  Chava B Pocernich; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2011-10-12

2.  Acute administration of 5-oxoproline induces oxidative damage to lipids and proteins and impairs antioxidant defenses in cerebral cortex and cerebellum of young rats.

Authors:  Carolina Didonet Pederzolli; Caroline Paula Mescka; Bernardo Remuzzi Zandoná; Daniella de Moura Coelho; Angela Malysz Sgaravatti; Mirian Bonaldi Sgarbi; Angela Terezinha de Souza Wyse; Clóvis Milton Duval Wannmacher; Moacir Wajner; Carmen Regla Vargas; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

3.  Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.

Authors:  Christopher D Aluise; Renã A Sowell Robinson; Tina L Beckett; M Paul Murphy; Jian Cai; William M Pierce; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2010-04-23       Impact factor: 5.996

4.  6-hydroxy-L-nicotine from Arthrobacter nicotinovorans sustain spatial memory formation by decreasing brain oxidative stress in rats.

Authors:  Lucian Hritcu; Marius Stefan; Roderich Brandsch; Marius Mihasan
Journal:  J Physiol Biochem       Date:  2012-06-20       Impact factor: 4.158

5.  Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.

Authors:  Rukhsana Sultana; William A Banks; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2010-02-15       Impact factor: 4.164

Review 6.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

7.  Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.

Authors:  Michela Guglielmotto; Luca Giliberto; Elena Tamagno; Massimo Tabaton
Journal:  Front Aging Neurosci       Date:  2010-02-09       Impact factor: 5.750

Review 8.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

Review 9.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

10.  LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Authors:  Brian P Brennan; J Eric Jensen; Christine Perriello; Harrison G Pope; Michael A Jenike; James I Hudson; Scott L Rauch; Marc J Kaufman
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.